Diurnal Fluctuation of Leukocyte G6PD Activity. A Possible Explanation for the Normal Neutrophil Bactericidal Activity and the Low Incidence of Pyogenic Infections in Patients with Severe G6PD Deficiency in Israel

Pediatric Research

Volumn 55, Issue 5, 2004, Pages 807-813

  Wolach, Baruch ^c   Ashkenazi, Meir ^d   Grossmann, Rami ^d   Gavrieli, Ronit ^d   Friedman, Ziva ^d   Bashan, Nava ^a   Roos, Dirk ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MEIR MEDICAL CENTER   (Israel)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEXOSE PHOSPHATE; SUPEROXIDE;

ADOLESCENT; ADULT; ARTICLE; BACTERICIDAL ACTIVITY; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INCIDENCE; INFANT; LEUKOCYTE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; NEWBORN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; ANEMIA, HEMOLYTIC, CONGENITAL; ANIONS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CIRCADIAN RHYTHM; ERYTHROCYTES; ESCHERICHIA COLI; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; ISRAEL; LEUKOCYTES; MIDDLE AGED; NEUTROPHILS; OXYGEN; PHAGOCYTOSIS; SUPEROXIDES; TIME FACTORS;

EID: 1942533637     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000120680.47846.47     Document Type: Article

References (43)

1. Beutler E 1994 Glucose-6-phosphate dehydrogenase deficiency. Blood 84:3613-3636
2. Beutler E 1990 The genetics of glucose-6-phosphate dehydrogenase deficiency. Semin Hematol 27:137-164
3. Zaidman JL, Leiba H, Scharf S, Steinman I 1976 Red cell glucose-6-phosphate dehydrogenase deficiency in ethnic groups in Israel. Clin Genet 9:131-133
4. Szeinberg A, Sheba CH, Adam A 1958 Selective occurrence of glutathione instability in red blood cell corpuscles of the various Jewish tribes. Blood 13:1043-1053
5. Kurdi-Haidor B, Mason PJ, Berrebi A, Ankra-Badu G, Al-Ali A, Oppenheim A, Luzzatto L 1990 Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet 47:1013-1019
6. + flux. Nature 416:291-297
7. Anderson M, Zasloff M 1999 Antimicrobial peptides: complementing classical inflammatory mechanisms of defense. In: Gallin J, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates, 3rd Ed. Lippincott Williams & Wilkins, Philadelphia, pp 1279-1292
8. Levy O 2000 Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96: 2664-2672
9. Wolach B, Baehner RL, Boxer LA 1982 Review: Clinical and laboratory approach to the management of neutrophil dysfunction. Isr J Med Sci 18:897-916
10. Ramot B, Fisher SH, Szeinberg A, Adam A, Sheba CH, Gafni D 1959 A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes. J Clin Invest 38:2234-2237
11. Newburger PE, Malawista SE, Dinauer MC, Gelbart T, Woodman RC, Chada S, Shen Q, van-Blaricom G, Quie PG, Cumutte JT 1994 Chronic granulomatous disease and glutathione peroxidase deficiency, revisited. Blood 84:3861-3869
12. Cooper MR, DeChatelet LR, McCall CE, LaVia MF, Spurr CL, Baehner RL 1972 Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest 51:769-778
13. Mamlok RJ, Mamlok V, Mills GC, Daeschner III CW, Schmalstieg FC, Anderson DC 1987 Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and chromobacterium violaceum sepsis. J Pediatr 111:852-854
14. Vives Corrons JL, Feliu E, Pujades MA, Cardellach F, Rozman C, Carreras A, Jou JM, Vallespi MT, Zuazu FJ 1982 Severe glucose-6- phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). Blood 59:428-434
15. Rodey GE, Jacob HS, Holmes B, McArthur JR, Good RA 1970 Leukocyte G6PD level and bactericidal activity. Lancet 1:355-356
16. Baehner RL, Johnston Jr RB, Nathan DG 1972 Comparative study of the metabolic and bactericidal characteristics of severely glucose-6 phosphate dehydrogenase-deficient polymorphonuclear leukocytes and leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc 12:150-169
17. Gray GR, Klebanoff SJ, Stamatoyannopoulus G, Austin T, Naiman C, Yoshida A, Kliman MR, Robinson GCF 1973 Neutrophil dysfunction, chronic granulomatous disease and non-spherocytic haemolytic anemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 2:530-534
18. Roos D, van Zwieten R, Wijnen JT, Gomez-Gallego F, de Boer M, Stevens D, Pronk-Admiraal CJ, de Rijk T, van Noorden CJF, Weening RS, Vulliamy TJ, Ploem JE, Mason PJ, Bautista JM, Khan PM, Beutler E 1999 Molecular basis and enzymatic properties of glucose-6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 94:2955-2962
19. Van Bruggen R, Bautista JM, Petropoulou T, de Boer M, van Zwieten R, Gómez-Gallego F, Belohradsky BH, Hartwig NG, Mason PJ, Roos D 2002 Deletion of leucine-61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100:1026-1030
20. Mallouh AA, Abu-Osba YK 1987 Bacterial infections in children with glucose-6-phosphate dehydrogenase deficiency. J Pediatr 111:850-852
21. Iancovici-Kidon, Sthoeger D, Abrahamov A, Wolach B, Beutler E, Gelbart T, Barak Y 2000 A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes. Blood Cells Mol Dis 26:567-571
22. Wolach B 1997 Neonatal sepsis: pathogenesis and supportive therapy. Semin Perinatol 21:28-38
23. Greenough A 1996 Bacterial sepsis and meningitis. Semin Neonatol 1:147-159
24. Böyum A 1968 Separation of leukocytes from blood and bone marrow. Scand J Lab Invest 97:7
25. Betke K, Beutler E, Brewer GJ, Kirkman HN, Luzzato L, Motulsky AG, Ramot B, Siniscalco M 1967 Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO scientific group. World Health Organ Tech Rep Ser 366:1-53
26. Newburger PE, Pagano JS, Greenberger JS, Karpas A, Cohen HJ 1980 Dissociation of opsonised particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line. J Cell Biol 85:549-557
27. Rister M, Baehner RL 1977 Effect of hyperoxia on superoxide anion and hydrogen peroxide production of polymorphonuclear leukocytes and alveolar macrophages. Br J Haematol 36:241-248
28. Clawson CC, Repine JE 1976 Quantitation of maximal bactericidal capability in human neutrophils. Lab Clin Med J 88:316-327
29. Wolach B, Sonnenschein D, Gavrieli R, Chomsky O, Pomeranz A, Yuli I 1998 The neonatal neutrophil inflammatory responses: correlation of light scattering with cell polarization, chemotaxis, superoxide release and bactericidal activity. Am J Hematol 157:8-15
30. Beutler E, Kuhl W 1990 The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am J Hum Genet 47:1008-1012
31. Kirkman HN, Riley Jr HD, Crowell BB 1960 Different enzymatic expressions of mutants of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci U S A 46:938-944
32. Rozenszajn LA, Joseph D 1974 The isoenzyme patterns of glucose-6-phosphate dehydrogenase in blood cells, bone marrow and other human tissues. Biochim Biophys Acta 364:38-44
33. Chan TK, Todd D, Wong CC 1965 Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency. J Lab Clin Med 66:937-942
34. Brok-Simoni F, Ashkenazi YE, Ramot B, Holtzman F 1976 The diumal rhythm of enzymes in human red cells. Br J Haematol 32:601-607
35. Petty HR, Kindzelskii AL 2001 Dissipative metabolic patterns respond during neutrophil transmembrane signaling. Proc Natl Acad Sci U S A 98:3145-3149
36. Goldbeter A 1996 Biochemical Oscillations and Cellular Rhythms. Cambridge University Press, Cambridge, UK
37. Wolach B, Canni D, Gilboa S, Satar M, Dolfin T, Schlesinger M 1994 Some aspects of the humoral immunity and the phagocytic function in newborn infants. Isr J Med Sci 30:331-335
38. Ben Dor M, Ashkenazi M, Rozenzajn LA, Wolach B 1988 Bactericidal activity of phagocytic cells in neonates. Harefuah 114:332-335
39. Wolach B, Gavrieli R, Pomeranz A 2000 Effect of granulocyte and granulocyte macrophage colony stimulating factors (G-CSF and GM-CSF) on neonatal neutrophil functions Pediatr Res 48:1-5
40. Yamazaki M, Matsuoka T, Yasui K, Komiyama A, Akabana T 1988 Increased production of superoxide anion by neonatal polymorphonuclear leukocytes stimulated with chemotactic peptide. Am J Hematol 27:169-173
41. Wolach B, Ben Dor M, Chomsky O, Gavrieli R, Shinitzky M 1992 Improved chemotactic ability of neonatal polymorphonuclear cells induced by mild membrane rigidification. J Leuk Biol 51:324-328
42. Levy O, Martin S, Eichenwald E, Ganz T, Valore E, Caroll SF, Lee K, Goldmann D, Thorne GM 1999 Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 104:1327-1333
43. Nupponen I, Turunen R, Nevalainen T, Peuravuri H, Pohjavuori M, Repo H, Andersson S 2002 Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr Res 51:670-674